NCT06800612 Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers Status RECRUITING Phase N/A
NCT06799637 Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments Status RECRUITING Phase PHASE1/PHASE2
NCT06799065 First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer Status RECRUITING Phase PHASE1
NCT06798610 The Impact of the Inflammation Index on Predicting Postoperative Complications in Ovarian Cancer Status COMPLETED Phase N/A
NCT06792435 XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. Status RECRUITING Phase PHASE1/PHASE2
NCT06787807 Proteomic Analysis of Patients Undergoing Bariatric Surgery Status NOT_YET_RECRUITING Phase NA
NCT06787612 Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer Status RECRUITING Phase PHASE2
NCT06778863 A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation Status RECRUITING Phase PHASE1
NCT06777147 Reproductive Health Outcomes in Young Patients with Ovarian Cancer After Surgical Treatment: a Retrospective Study Status NOT_YET_RECRUITING Phase N/A
NCT06775470 Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer Status RECRUITING Phase N/A
NCT06769152 A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors Status RECRUITING Phase PHASE2
NCT06760702 A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers Status TERMINATED Phase PHASE2
NCT06760507 Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics Status RECRUITING Phase NA
NCT06751524 Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval Status AVAILABLE Phase N/A
NCT06751485 JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT06751303 Patient Preferences for Precision Medicine: Determining Optimal Patient Quality of Life Using PARPi's Status RECRUITING Phase NA
NCT06738966 A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer Status RECRUITING Phase PHASE1
NCT06735326 Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer Status RECRUITING Phase PHASE2